Correlation Between JIN MEDICAL and Innerscope Advertising

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JIN MEDICAL and Innerscope Advertising at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JIN MEDICAL and Innerscope Advertising into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JIN MEDICAL INTERNATIONAL and Innerscope Advertising Agency, you can compare the effects of market volatilities on JIN MEDICAL and Innerscope Advertising and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JIN MEDICAL with a short position of Innerscope Advertising. Check out your portfolio center. Please also check ongoing floating volatility patterns of JIN MEDICAL and Innerscope Advertising.

Diversification Opportunities for JIN MEDICAL and Innerscope Advertising

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between JIN and Innerscope is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding JIN MEDICAL INTERNATIONAL and Innerscope Advertising Agency in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innerscope Advertising and JIN MEDICAL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JIN MEDICAL INTERNATIONAL are associated (or correlated) with Innerscope Advertising. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innerscope Advertising has no effect on the direction of JIN MEDICAL i.e., JIN MEDICAL and Innerscope Advertising go up and down completely randomly.

Pair Corralation between JIN MEDICAL and Innerscope Advertising

Given the investment horizon of 90 days JIN MEDICAL INTERNATIONAL is expected to under-perform the Innerscope Advertising. But the stock apears to be less risky and, when comparing its historical volatility, JIN MEDICAL INTERNATIONAL is 4.04 times less risky than Innerscope Advertising. The stock trades about -0.05 of its potential returns per unit of risk. The Innerscope Advertising Agency is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  50.00  in Innerscope Advertising Agency on August 29, 2024 and sell it today you would lose (43.00) from holding Innerscope Advertising Agency or give up 86.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

JIN MEDICAL INTERNATIONAL  vs.  Innerscope Advertising Agency

 Performance 
       Timeline  
JIN MEDICAL INTERNATIONAL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days JIN MEDICAL INTERNATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Innerscope Advertising 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innerscope Advertising Agency has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

JIN MEDICAL and Innerscope Advertising Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JIN MEDICAL and Innerscope Advertising

The main advantage of trading using opposite JIN MEDICAL and Innerscope Advertising positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JIN MEDICAL position performs unexpectedly, Innerscope Advertising can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innerscope Advertising will offset losses from the drop in Innerscope Advertising's long position.
The idea behind JIN MEDICAL INTERNATIONAL and Innerscope Advertising Agency pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account